Non-alcoholic Fatty Liver Diseases (NAFLD) Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Effect of Multi-ingredient on Visceral Adiposity & Non-alcoholic Fatty Liver Disease in Postmenopausal Women With Abdominal Obesity
Conditions: Visceral Obesity; Non-alcoholic Fatty Liver; Postmenopausal Interventions: Dietary Supplement: Multi-ingredient of L-histidine, L-serine, L-carnosine and N-Acetylcysteine; Dietary Supplement: Placebo Sponsors: Fundaci ó Eurecat; Centre de Diagnosi per la Imatge; Instituto de Investigación Biomédica de Girona (IDIBGI); Laboratorio de Referencia de Cataluña Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 22, 2024 Category: Research Source Type: clinical trials

Fibrosis Lessens After Metabolic Surgery
Conditions: Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD); Non-Alcoholic Fatty Liver Disease; Metabolic Dysfunction-Associated Steatohepatitis (MASH); Liver Fibrosis; Obesity Interventions: Procedure: Metabolic surgery; Drug: Incretin-Based Therapy Sponsors: Ali Aminian Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2024 Category: Research Source Type: clinical trials

MASLD in Primary Hypothyroidism and Efficacy of Dapaglifozin
Conditions: Hepatic Steato-Fibrosis; Non-Alcoholic Fatty Liver Disease Interventions: Drug: Dapagliflozin 10mg Tab; Drug: Placebo; Drug: Levothyroxine Replacement daily Sponsors: Post Graduate Institute of Medical Education and Research, Chandigarh Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials

Efficacy and Safety of Antiviral Therapy With Peg-interferon for Chronic Hepatitis B Complicated With Nonalcoholic Fatty Liver Disease （OCEAN PROJECT）
Conditions: Nonalcoholic Fatty Liver Disease; Chronic Hepatitis b Interventions: Drug: Peg-Interferon α Sponsors: First Affiliated Hospital of Wenzhou Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials

The Study of Lithogenesis Processes in Patients With Non-alcoholic Fatty Liver Disease (NAFLD)
Conditions: NAFLD; Urinary Lithiasis Sponsors: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials

An Imaging-based Quantitative Biomarker Assay for NAFLD in Children
Conditions: NAFLD; NASH Interventions: Device: Magnetic Resonance Imaging (MRI); Device: Ultrasound (US) Sponsors: University of Wisconsin, Madison Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials

Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease
Conditions: Non-Alcoholic Fatty Liver Disease Interventions: Drug: Empagliflozin 10 MG; Drug: Placebo Oral Tablet Sponsors: Ann& Robert H Lurie Children ' s Hospital of Chicago Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials

Human Models of Selective Insulin Resistance: Alpelisib, Part I
Conditions: Insulin Resistance; Prediabetic State; Overweight and Obesity; Non-Alcoholic Fatty Liver Disease Interventions: Drug: Alpelisib 300 mg; Drug: Placebo; Drug: [1-13C] sodium acetate; Drug: [6,6-2H2] D-glucose; Dietary Supplement: Nestl é BOOST Plus Sponsors: Columbia University; University of California, Berkeley Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials

Motivational Interviewing in the Management of Non Alcoholic Fatty Liver Disease
Conditions: Non-Alcoholic Fatty Liver Disease Interventions: Behavioral: Motivational Interview; Behavioral: Placebo Sponsors: Madunil Anuk Niriella Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2024 Category: Research Source Type: clinical trials

AGED Diagnostics Liver Disease Assessment
Conditions: NASH With Fibrosis; NAFLD; Healthy Interventions: Diagnostic Test: AGED Multiple Target Assay in Healthy Controls; Diagnostic Test: AGED Multiple Target Assay in NAFLD Participants; Diagnostic Test: AGED Multiple Target Assay in Fibrosis Participants Sponsors: Active Genomes Expressed Diagnostics, Corp; Arizona Clinical Trials; Walter Reed National Military Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2024 Category: Research Source Type: clinical trials

Effect of Consumption of Millet Diet in Patients With NAFLD
Conditions: NAFLD Interventions: Other: jowar based products Sponsors: Institute of Liver and Biliary Sciences, India Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials

The Impact of Different Exercise Modes on Bile Acid Levels and Liver Function in Patients With Non-alcoholic Fatty Liver Disease
Conditions: Non-alcoholic Fatty Liver Disease NAFLD Interventions: Behavioral: Aerobic training (AT); Behavioral: Resistance training (RT); Behavioral: Combined aerobic and resistance training (AT + RT) Sponsors: Xuzhou Medical University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials

Manual Therapy in Metabolic Liver Disease
Conditions: NAFLD, Non-alcoholic Fatty Liver Disease Interventions: Procedure: liver treatment protocol Sponsors: University of Seville Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials

The Efficacy of Pedometer-motivated Physical Activity for the Management of Patients With MASLD.
Conditions: Daily Step Count; MASLD; BMI; Metabolic Syndrome; NAFLD; Insulin Resistance; Genetic Polymorphism; Cardiovascular Disease (CVD) Interventions: Other: Encourage using pedometer Sponsors: Mahidol University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2024 Category: Research Source Type: clinical trials

Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity
Conditions: Obesity; Nonalcoholic Fatty Liver; Diabetes Type 2; Healthy Interventions: Other: Dietary consultation weight loss intervention Sponsors: Bettina Mittendorfer; National Institutes of Health (NIH); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2024 Category: Research Source Type: clinical trials